MENU
+Compare
ADAP
Stock ticker: NASDAQ
AS OF
Aug 7 closing price
Price
$0.08
Change
-$0.00 (-0.00%)
Capitalization
22M

ADAP Adaptimmune Therapeutics plc Forecast, Technical & Fundamental Analysis

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies... Show more

Industry: #Biotechnology
ADAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ADAP with price predictions
Aug 07, 2025

ADAP sees MACD Histogram crosses below signal line

ADAP saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 28, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ADAP as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ADAP moved below its 50-day moving average on July 28, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ADAP crossed bearishly below the 50-day moving average on July 29, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADAP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ADAP advanced for three days, in of 217 cases, the price rose further within the following month. The odds of a continued upward trend are .

ADAP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 123 cases where ADAP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.921) is normal, around the industry mean (18.130). P/E Ratio (0.000) is within average values for comparable stocks, (57.859). ADAP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.470). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.114) is also within normal values, averaging (276.117).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ADAP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADAP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ADAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ADAP is expected to report earnings to rise 9.33% to -3 cents per share on November 05

Adaptimmune Therapeutics plc ADAP Stock Earnings Reports
Q3'25
Est.
$-0.03
Q1'25
Beat
by $0.09
Q4'24
Missed
by $0.02
Q3'24
Est.
$-0.01
Q2'24
Beat
by $0.09
The last earnings report on May 13 showed earnings per share of -2 cents, beating the estimate of -11 cents. With 58.74M shares outstanding, the current market capitalization sits at 22.00M.
A.I. Advisor
published General Information

General Information

a manufacturer of vaccines and cancer immunotherapy products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
60 Jubilee Avenue
Phone
+44 1235430000
Employees
449
Web
https://www.adaptimmune.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMTS18.620.62
+3.44%
CPI Card Group
CMI384.612.93
+0.77%
Cummins
ELEV0.37N/A
N/A
Elevation Oncology Inc
TLX11.78-0.19
-1.59%
Telix Pharmaceuticals Ltd.
WEST6.64-0.35
-5.01%
Westrock Coffee Company

ADAP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ADAP has been loosely correlated with CANF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ADAP jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAP
1D Price
Change %
ADAP100%
+3.36%
CANF - ADAP
42%
Loosely correlated
+1.40%
AKBA - ADAP
41%
Loosely correlated
-20.48%
ORMP - ADAP
36%
Loosely correlated
-0.24%
CSLLY - ADAP
32%
Poorly correlated
-1.32%
OVID - ADAP
32%
Poorly correlated
+0.25%
More